Associations Between PADI4 Gene Polymorphisms and Rheumatoid Arthritis: An Updated Meta-analysis

Archives of Medical Research

Volumn 46, Issue 4, 2015, Pages 317-325

  Yang, Xiao ke ^a   Liu, Juan ^a   Liu, Jie ^a   Liang, Yan ^a   Xu, Wang dong ^a   Leng, Rui xue ^a   Pan, Hai feng ^a   Ye, Dong qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; PADI4; Polymorphism; Rheumatoid arthritis

Indexed keywords

PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 4; UNCLASSIFIED DRUG; HYDROLASE; PEPTIDYLARGININE DEIMINASE TYPE IV;

AFRICAN; ALLELE; ARTICLE; ASIAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HISPANIC; HUMAN; RHEUMATOID ARTHRITIS; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROLASES; POLYMORPHISM, GENETIC;

EID: 84936940480     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.05.011     Document Type: Article

References (49)

1. Lee Y.H., Bae S.C., Choi S.J., et al. Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 2012, 39:10627-10635.
2. Song G.G., Bae S.C., Lee Y.H. Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Rheumatol Int 2014, 34:1529-1537.
3. Mohan V.K., Ganesan N., Gopalakrishnan R. Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis. J Genet 2014, 93:597-605.
4. Kurkó J., Besenyei T., Laki J., et al. Genetics of rheumatoid arthritis-a comprehensive review. Clin Rev Allergy Immunol 2013, 45:170-179.
5. Zhou Z., Menard H.A. Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis?. Curr Opin Rheumatol 2002, 14:250-253.
6. Kinloch A., Lundberg K., Wait R., et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008, 58:2287-2295.
7. Chang X., Zhao Y., Sun S., et al. The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 2009, 29:1411-1416.
8. Suzuki A., Yamada R., Chang X., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402.
9. Harney S.M., Meisel C., Sims A.M., et al. Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:869-872.
10. Chang X., Yamada R., Suzuki A., et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005, 44:40-50.
11. Hoppe B., Haupl T., Gruber R., et al. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther 2006, 8:R34.
12. Plenge R.M., Padyukov L., Remmers E.F., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005, 77:1044-1060.
13. Martinez A., Valdivia A., Pascual-Salcedo D., et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 2005, 44:1263-1266.
14. Ikari K., Kuwahara M., Nakamura T., et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 2005, 52:3054-3057.
15. Chen R., Wei Y., Cai Q., et al. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatol Int 2011, 31:1631-1634.
16. Takata Y., Inoue H., Sato A., et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 2008, 53:163-173.
17. Burr M.L., Naseem H., Hinks A., et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 2010, 69:666-670.
18. Abd-Allah S.H., el-Shal A.S., Shalaby S.M., et al. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients. Joint Bone Spine 2012, 79:124-128.
19. Barton A., Bowes J., Eyre S., et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004, 50:1117-1121.
20. Kang C.P., Lee H.S., Ju H., et al. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006, 54:90-96.
21. Costenbader K.H., Chang S.C., De Vivo I., et al. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther 2008, 10:R52.
22. Poór G., Nagy Z.B., Schmidt Z., et al. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Ann N Y Acad Sci 2007, 1110:23-32.
23. Kochi Y., Thabet M.M., Suzuki A., et al. PADI4 polymorphism predisposes male smokers to rheumatoid arthritis. Ann Rheum Dis 2011, 70:512-515.
24. Feng Z.J., Niu H.Z., Liang Y., et al. Association between rheumatoid arthritis and single nucleotide polymorphisms of padi4-104 in Han population in Hebei province. J Mol Diagn Ther 2010, 2:244-247. (in Chinese).
25. Cui L.F., Yang W.H., Song H.C., et al. Association of polymorphism of peptidylarginine deiminase 4 gene and rheumatoid arthritis in Han population. Chin J Allergy Clin Immunol 2007, 1:158-162. (in Chinese).
26. Zhong B., Fang Y.F., Li H., et al. Correlation of peptidylarginine deiminase 4 gene polymorphism and rheumatoid arthritis. J Third Militar Med Univ 2010, 32:1155-1157. (in Chinese).
27. Shi H.X., Qian L., Li X.P., et al. Association of polymorphism of peptidylarginine deaminase-4 gene and rheumatoid arthritis. Chin J Rheumatol 2010, 14:336-339. (in Chinese).
28. Cui L.F., Yuan W., Yang W.H., et al. Association of polymorphism of peptidylarginine deiminase 4 (PADI4) gene with rheumatoid arthritis and anti-cyclic citrullinated peptide antibody. Chin J Basic Med Tradit Chin Med 2011, 17:630-632. (in Chinese).
29. Li H.B., Tie N., Jia Y.F., et al. Association between the synovial expression of cyclic citrallinated petide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphism in patients with rheumatoid arthritis. Natl Med J China 2012, 92:1607-1611. (in Chinese).
30. Li Q., Lin K.Q., Li Q., et al. Association of polymorphism of PTPN22 and PADI4 genes with rheumatoid arthritis in Yunnan. Chin J Med Genet 2013, 30:111-115. (in Chinese).
31. Panati K., Pal S., Rao K.V., et al. Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population. Genes Genet Syst 2012, 87:191-196.
32. Ben Hassine H., Zemni R., Bouagina E., et al. Lack of association between PADI4 polymorphisms and rheumatoid arthritis in the Tunisian population. Joint Bone Spine 2012, 79:329-330.
33. Zavala-Cerna M.G., Gonzalez-Montoya N.G., Nava A., et al. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation. Clin Dev Immunol 2013, 2013:383681.
34. Cheng J., Zhang H., Zhuang C., et al. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J Rheumatol 2012, 39:1159-1165.
35. Liu Y., Yang F.M., Zhang P.L., et al. Correlation between PADI4 gene polymorphisms and rheumatoid arthritis in Han, Hui and Tibetan people of plateau area. Chin J Gerontol 2012, 32:3881-3883. (in Chinese).
36. Du Y., Liu X., Guo J.P., et al. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort. Clin Exp Rheumatol 2014, 32:377-382.
37. Xu W.D., Peng H., Zhou M., et al. Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2013, 40:941-948.
38. Iwamoto T., Ikari K., Nakamura T., et al. Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) 2006, 45:804-807.
39. Hou S., Gao G.P., Zhang X.J., et al. PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 2013, 23:50-60.
40. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
41. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
42. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
43. Fan L.Y., Wang W.J., Wang Q., et al. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens 2008, 72:469-473.
44. Chang X., Xia Y., Pan J., et al. PADI2 is significantly associated with rheumatoid arthritis. PLoS One 2013, 8:e81259.
45. Suzuki T., Ikari K., Yano K., et al. PADI4 and HLA-DRB1 Are genetic risks for radiographic progression in RA patients, independent of ACPA status: Results from the IORRA Cohort Study. PLoS One 2013, 8:e61045.
46. Meziani R., Yamada R., Takahashi M., et al. A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations. Mod Rheumatol 2012, 22:52-58.
47. Prasad P., Kumar A., Gupta R., et al. Caucasian and Asian specific rheumatoid arthritis risk loci reveal limited replication and apparent allelic heterogeneity in North Indians. PLoS One 2012, 7:e31584.
48. Ceccarelli F., D'Alfonso S., Perricone C., et al. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 2012, 30:939-942.
49. Liu Y., Yang F.M., Li R., et al. Anti-cyclic citrullinated peptide antibody and serum peptidylarginine deiminase polymorphism in rheumatoid arthritis patients in Qinghai Hui population. Chin Gen Practice 2012, 15:3734-3736. (in Chinese).